153 related articles for article (PubMed ID: 32180728)
1. Early Chronic Carbamazepine-in-Food Administration to MAM/Pilocarpine Rats Does Not Affect Convulsive Motor Seizures.
Nobili P; Cattalini A; de Grazia U; Cagnoli C; de Curtis M; Battaglia GS; Colciaghi F
Front Pharmacol; 2020; 11():181. PubMed ID: 32180728
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
[TBL] [Abstract][Full Text] [Related]
3. Continuous neurodegeneration and death pathway activation in neurons and glia in an experimental model of severe chronic epilepsy.
Nobili P; Colciaghi F; Finardi A; Zambon S; Locatelli D; Battaglia GS
Neurobiol Dis; 2015 Nov; 83():54-66. PubMed ID: 26264964
[TBL] [Abstract][Full Text] [Related]
4. A once-per-day, drug-in-food protocol for prolonged administration of antiepileptic drugs in animal models.
Ali A; Dua Y; Constance JE; Franklin MR; Dudek FE
Epilepsia; 2012 Jan; 53(1):199-206. PubMed ID: 22092257
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols.
Grabenstatter HL; Clark S; Dudek FE
Epilepsia; 2007 Dec; 48(12):2287-95. PubMed ID: 17711461
[TBL] [Abstract][Full Text] [Related]
6. Effect of carbamazepine on spontaneous recurrent seizures recorded from the dentate gyrus in rats with kainate-induced epilepsy.
Grabenstatter HL; Dudek FE
Epilepsia; 2019 Apr; 60(4):636-647. PubMed ID: 30815862
[TBL] [Abstract][Full Text] [Related]
7. Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus.
Löscher W; Hönack D
Epilepsia; 1997 Jan; 38(1):106-13. PubMed ID: 9024191
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine enhances discriminative memory in a rat model of epilepsy.
Bernardi RB; Barros HM
Epilepsia; 2004 Nov; 45(11):1443-7. PubMed ID: 15509245
[TBL] [Abstract][Full Text] [Related]
10. CNS autoimmune response in the MAM/pilocarpine rat model of epileptogenic cortical malformation.
Costanza M; Ciotti A; Consonni A; Cipelletti B; Cattalini A; Cagnoli C; Baggi F; de Curtis M; Colciaghi F
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2319607121. PubMed ID: 38635635
[TBL] [Abstract][Full Text] [Related]
11. Status epilepticus-induced pathologic plasticity in a rat model of focal cortical dysplasia.
Colciaghi F; Finardi A; Frasca A; Balosso S; Nobili P; Carriero G; Locatelli D; Vezzani A; Battaglia G
Brain; 2011 Oct; 134(Pt 10):2828-43. PubMed ID: 21482549
[TBL] [Abstract][Full Text] [Related]
12. Effect on epileptogenesis of carbamazepine treatment during the silent period of the pilocarpine model of epilepsy.
Capella HM; Lemos T
Epilepsia; 2002; 43 Suppl 5():110-1. PubMed ID: 12121304
[TBL] [Abstract][Full Text] [Related]
13. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
[TBL] [Abstract][Full Text] [Related]
14. Pilocarpine-induced seizure susceptibility in rats following prenatal methylazoxymethanol treatment.
Choi IS; Cho JH; Lee MG; Choi BJ
Biol Pharm Bull; 2005 Aug; 28(8):1408-13. PubMed ID: 16079484
[TBL] [Abstract][Full Text] [Related]
15. Intravenous carbamazepine for the treatment of epilepsy.
Brigo F; Leo A; Russo E; Striano P; Belcastro V
Expert Opin Pharmacother; 2018 May; 19(7):743-747. PubMed ID: 29648925
[TBL] [Abstract][Full Text] [Related]
16. Transplacentally induced neuronal migration disorders: an animal model for the study of the epilepsies.
Germano IM; Sperber EF
J Neurosci Res; 1998 Feb; 51(4):473-88. PubMed ID: 9514201
[TBL] [Abstract][Full Text] [Related]
17. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
Powell G; Saunders M; Marson AG
Cochrane Database Syst Rev; 2014 Feb; (2):CD007124. PubMed ID: 24488654
[TBL] [Abstract][Full Text] [Related]
18. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
Powell G; Saunders M; Rigby A; Marson AG
Cochrane Database Syst Rev; 2014 Dec; (12):CD007124. PubMed ID: 25470302
[TBL] [Abstract][Full Text] [Related]
19. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
20. Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy.
Citraro R; Scicchitano F; De Fazio S; Raggio R; Mainardi P; Perucca E; De Sarro G; Russo E
Epilepsy Res; 2011 Jun; 95(1-2):60-9. PubMed ID: 21458955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
